by Usha Govindarajulu | Mar 27, 2024 | Biostatistics, Blog, Usha Govindarajulu
March 27, 2024 In this article, the authors described their Schemper-Henderson measure to account for explained variation for survival outcomes, extended to allow for competing risks. They defied explained variation as the relative gain in predictive accuracy when...
by Usha Govindarajulu | Mar 13, 2024 | Biostatistics, Blog, Usha Govindarajulu
March 13, 2024 New immunotherapies for cancer have shown to have different treatment effects often with delay compared to other cytotoxic treatments and, therefore, this has called for different ways of modeling the survival curves. The usual log-rank test has relied...
by Usha Govindarajulu | Feb 28, 2024 | Blog
February 26, 2024 TABLE 1. Summary of the available methods for survival regression with competing risks (CR). Model Type Proportional hazards (PH) High dimensions (�) Missing data Approaches based on a cause-specific hazard specification Cox proportional CS hazard...
by Usha Govindarajulu | Feb 14, 2024 | Blog
In an article in Biometrical Journal, Heinze et al discussed phases of methodological research in biostatistics. The authors of this publication are all members of an international STRATOS (STRengthening Analytical Thinking for Observational Studies) Intiative, whose...
by Usha Govindarajulu | Jan 31, 2024 | Biostatistics, Blog, COVID-19, Usha Govindarajulu
January 31, 2024 In an article that appeared in Biometrical Journal, Hu described a new random-intercept accelerated failure time model with Bayesian additive regression trees (riAFT-BART), which can be used to draw causal inferences on population treatment effectts...
